Overexpression of BGN at mRNA and/or protein level has been associated with advanced tumor stages, metastases development, drug resistance, and poor prognosis in patients with ovarian, prostate, oral, colon, and gastric cancers [11, 16, 21, 22, 36]. This evidence concerns the gene BGN and gastric cancer.